Release Date: 11/10/12 13:52 Summary: Managing Directors Presentation to Shareholders - AGM Price Sensitive: No Download Document 598.96KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%